What is naltrexone for alcohol?
Naltrexone is an FDA-approved medication for alcohol dependence that works by blocking opioid receptors in the brain, reducing alcohol cravings and the rewarding effects of drinking. In 2024, only 2.5% of the 27.9 million Americans with alcohol use disorder received medication-assisted treatment.
Naltrexone is one of three medications the FDA has approved for alcohol dependence, and the one most often described in terms of what it does to the pull of a drink. The plain question worth answering is not whether it works in general, but what it actually does inside the brain, what it is for, and where that leaves the parts a general article cannot settle.
What it does in the brain
Part of why a drink feels good is chemical. Alcohol nudges the brain to release its own feel-good signals — the same natural chemicals, sometimes called endorphins, that give a lift after exercise or a good meal. Those signals land on docking points called opioid receptors, and that small rush of reward is part of what makes the next drink appealing.
Naltrexone sits on those same docking points and blocks them. SAMHSA describes it as binding to endorphin receptors and blocking the effects and feelings of alcohol, which it says can reduce cravings and the amount a person drinks. The American Academy of Family Physicians explains the logic the same way: because those receptors help carry the pleasant effects of alcohol, a drug that blocks them turns the reward down, so a drink feels less worth it. It does not make you sick and it does not sober you up faster. It quietly dials back the payoff.
That mechanism is why naltrexone is FDA-approved specifically for alcohol dependence, and also for blocking the effects of opioids — the same blocking action, aimed at a different target.
How it differs from the other two approved options
Naltrexone is easier to understand when you see it next to the other two medicines the FDA has approved, because all three chase the same goal by completely different routes. A peer-reviewed overview of the three lays out the split cleanly.
- Naltrexone blocks the reward. Drinking still happens without a dramatic reaction; it just feels less rewarding, so the urge to keep going tends to ease.
- Disulfiram works like a tripwire. It blocks the step that clears alcohol from your body, so a byproduct builds up and drinking on it makes you feel ill — the deterrent is the bad reaction itself.
- Acamprosate leaves reward alone and instead works on the restless, off-balance feeling that can linger for months after someone stops, helping a brain that ran on alcohol for a long time settle back toward normal.
Three tools, three jobs. Naltrexone is the one aimed at the wanting.
What the evidence supports, and where it stops
Naltrexone is not a fringe option. When the Agency for Healthcare Research and Quality reviewed the outpatient evidence, it found that oral naltrexone and acamprosate each carried moderate-strength evidence for reducing a return to drinking — the two best-supported oral choices among the approved medicines. AAFP reaches a similar place, calling naltrexone a useful addition to counseling and behavioral support rather than something to lean on alone.
What the evidence does not do is tell you it fits you. The same DailyMed label that carries the FDA indication also states plainly that naltrexone has not been shown to help except as part of a broader plan for managing alcohol use — a clinician's structure around it, not a pill taken in isolation. So the honest summary is narrow: it is a real, mainstream, reasonably well-supported medicine, and whether it belongs in one person's situation is a separate question the research cannot answer in the abstract.
The one caution worth knowing before anything else
There is a specific safety line that matters more than any other detail. Naltrexone is not for people taking opioid pain medication, currently dependent on opioids, or in opioid withdrawal. Because it blocks opioid receptors, it can knock out prescription pain relief and can push someone who relies on opioids into sudden, severe withdrawal. This is exactly the kind of thing you cannot reason your way around from a webpage. If opioids are anywhere in your picture — a recent prescription, past dependence, an upcoming surgery — that is the first thing a clinician needs to hear, not a footnote.
What to do with this
If you have read this far, you are already doing the uncommon thing. In 2024 an estimated 27.9 million people ages 12 and older in the United States had past-year alcohol use disorder, about 9.7% of that age group, per NIAAA.
Of them, only about 2.1 million received any alcohol treatment that year — roughly 7.6% — and the share who were offered a medication was smaller still. That gap is mostly not about the medicines failing; it is that the conversation rarely happens, because no one raises it and shame keeps people from asking. Looking this up is the step most people never take.
From here, a few concrete moves:
- If your goal is cutting back rather than quitting entirely, say so out loud. Naltrexone is one of the few options studied for people who are still drinking, not only for those already stopped, so naming the goal plainly helps a clinician point you the right way.
- Bring a real number, not a vague one. Roughly how many drinks, how often, in what settings. A standard drink in the U.S. is 0.6 fluid ounces of pure alcohol — about a 12-ounce beer, a 5-ounce glass of wine, or a 1.5-ounce shot. An honest count tells a clinician far more than "sometimes too much."
- Treat the opioid question as non-negotiable. Before naltrexone is even on the table, that history has to be on the record.
Clero exists to make that first conversation easier to have — connecting you with a licensed clinician by telehealth to review, in your own context, whether a medication like naltrexone is worth considering.
When it is more than a medication question
Sorting out a prescription is a calm, unhurried decision. Some situations are not. If cutting back or stopping brings on shaking, sweating, confusion, hallucinations, or a seizure, that is alcohol withdrawal and it can be dangerous — call 911 or go to an emergency room. If you are having thoughts of harming yourself, call or text 988, the Suicide and Crisis Lifeline, now. And for finding treatment when there is no immediate danger, SAMHSA's free, confidential National Helpline is 1-800-662-HELP.
Naltrexone, in the end, is a fairly simple idea: turn down the reward, and the wanting tends to follow. Whether that idea fits your body, your history, and your goals is the part worth taking to someone who can see all three.
This is general education, not medical advice or a prescription. Any decision about naltrexone belongs with a licensed clinician who knows your full history; if drinking or stopping ever brings thoughts of self-harm, call or text 988, and treat seizures, confusion, or hallucinations as a medical emergency at 911.
Want the private naltrexone update?
Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.